Stoke Therapeutics, Inc. (STOK)
Develops genetic disease treatments using special molecules that turn up protein production in the body.
$28.87-0.02%Healthcare
StockGlow Score
Leaning Bullish
BearishBullish
1 year ago+123.6%
The outlook
STOK is trading below both its 50- and 200-day moving averages, sitting midway through its 52-week range. Analyst consensus is Strong Buy with an average price target about 59% above the current price. The overall sentiment leans bullish despite recent price weakness.
What’s behind the score
Analyst consensusStrong Buy — 1.1 avg of 11 analysts
Price trendBelow its 50- & 200-day averages
52-week range59% of the way from its 52-week low to high
Price targetAvg target +59% vs current price
Analyst price target
~12-month · 11 analysts$45.82average target+58.7% vs now
Now $28.87
Low $35.00High $60.00
Published targets from Wall Street analysts (public data) — what analysts expect over roughly a year. This is not a StockGlow forecast and not a recommendation. Analyst targets are frequently wrong.
Market cap
$1.80B
52-wk high
$40.22
52-wk low
$12.25
50-day avg
$30.36
200-day avg
$31.67
Trailing P/E
—